Bank Of Nova Scotia Moderna, Inc. Transaction History

Bank Of Nova Scotia

$47.4 Billion
Q3 2024

A detailed history of Bank Of Nova Scotia transactions in Moderna, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 39,475 shares of MRNA stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,475

Previous 29,641 33.18%

Holding current value

$1.45 Million

Previous $3.52 Million 25.04%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $625,835 - $1.23 Million	9,834 Added 33.18%	39,475 $2.64 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $213,856 - $352,046	-2,113 Reduced 6.65%	29,641 $3.52 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $1.2 Million - $1.62 Million	-14,046 Reduced 30.67%	31,754 $3.38 Million
Q4 2023 Feb 12, 2024	BUY	$69.51 - $104.43 $1.29 Million - $1.94 Million	18,574 Added 68.22%	45,800 $4.55 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $578,460 - $759,660	6,000 Added 28.27%	27,226 $2.81 Million
Q2 2023 Aug 03, 2023	BUY	$118.5 - $160.53 $1.02 Million - $1.39 Million	8,644 Added 68.7%	21,226 $2.58 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $9.79 Million - $14.2 Million	-72,170 Reduced 85.15%	12,582 $1.93 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $8.53 Million - $15.1 Million	-72,046 Reduced 45.95%	84,752 $15.2 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $1.59 Million - $2.61 Million	-13,465 Reduced 7.91%	156,798 $18.5 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $19 Million - $28.6 Million	161,990 Added 1958.06%	170,263 $24.3 Million
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $21.8 Million - $32.8 Million	-185,958 Reduced 95.74%	8,273 $1.18 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $6.16 Million - $11.4 Million	-48,699 Reduced 20.05%	194,231 $33.5 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $30.6 Million - $49.9 Million	135,395 Added 125.91%	242,930 $61.8 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $9.45 Million - $20.6 Million	-42,573 Reduced 28.36%	107,535 $41.4 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $19.5 Million - $35.3 Million	150,108 New	150,108 $35.3 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Moderna, Inc. Transaction History